ARCHIVES

Revlimid Maintenance Therapy Delayed Progression by 90%

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977

NCAB Committee Close To Definition Of QRA

February 11, 1983

Schweiker Approves Transfer Of NTP’s NNCI Contribution To NIESH In FY’83

July 31, 1981

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

NCI National Lab’s Budget to Grow Over Its $299.2 Million FY2013 Level

February 28, 2014

GA101 Associated with Better PFS In Phase III Trial Versus Rituximab in CLL

July 26, 2013